Lorcaserin, a 5-HT2C receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages 837-845

  Martin, Corby K ^a   Redman, Leanne M ^a   Zhang, Jinkun ^b   Sanchez, Matilde ^b   Anderson, Christen M ^b   Smith, Steven R ^a,c   Ravussin, Eric ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b ARENA PHARMACEUTICALS   (United States)

^c FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORCASERIN; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; SATIETY; SELF REPORT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; APPETITE; BENZAZEPINES; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HEART RATE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; OVERWEIGHT; OXIDATION-REDUCTION; QUESTIONNAIRES; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN RECEPTOR AGONISTS; YOUNG ADULT;

EID: 79952297237     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1848     Document Type: Article

References (25)

1. NHLBI 1998 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S-209S
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR 2010 Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241
3. Blundell JE 1977 Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes 1:15-42
4. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D 1995 Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374:542-546
5. Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Shamma H, Smith B, Chalmers D, Behan D 2008 Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325:577-587 (Pubitemid 351574813)
6. Nichols DE 2004 Hallucinogens. Pharmacol Ther 101:131-181 (Pubitemid 38167565)
7. Launay JM, Hervé P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L 2002 Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8:1129-1135
8. Roth BL 2007 Drugs and valvular heart disease. N Engl J Med 356:6-9
9. 2C agonist, reduces body weight in obese men and women. Obesity (Silver Spring) 17:494-503
10. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanahan WR 2010 Multicenter placebo-controlled trial of lorcaserin for weight management. N Engl J Med 363:245-256
11. Smith BM, Smith JM, Tsai JH, Schultz JA, Gilson CA, Estrada SA, Chen RR, Park DM, Prieto EB, Gallardo CS, Sengupta D, Dosa PI, Covel JA, Ren A, Webb RR, Beeley NR, Martin M, Morgan M, Espitia S, Saldana HR, Bjenning C, Whelan KT, Grottick AJ, Menzaghi F, Thomsen WJ 2008 Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. J Med Chem 51:305-313
12. de Jonge L, Nguyen T, Smith SR, Zachwieja JJ, Roy HJ, Bray GA 2001 Prediction of energy expenditure in a whole body indirect calorimeter at both low and high levels of physical activity. Int J Obes Relat Metab Disord 25:929-934 (Pubitemid 32566045)
13. Martin CK, Williamson DA, Geiselman PJ, Walden H, Smeets M, Morales S, Redmann Jr S 2005 Consistency of food intake over four eating sessions in the laboratory. Eat Behav 6:365-372 (Pubitemid 41614447)
14. Flint A, Raben A, Blundell JE, Astrup A 2000 Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24:38-48 (Pubitemid 30098877)
15. Womble LG, Wadden TA, Chandler JM, Martin AR 2003 Agreement between weekly vs. daily assessment of appetite. Appetite 40:131-135
16. Beck AT, Brown GK, Steer RA 1996 Beck Depression Inventory-II. San Antonio, TX: Psychological Corp.
17. Stunkard AJ, Messick S 1988 Eating Inventory Manual (The Psychological Corporation). San Antonio, TX: Harcourt Brace
18. White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG 2002 Development and validation of the food-craving inventory. Obes Res 10:107-114 (Pubitemid 135687498)
19. Cooper PJ, Taylor MJ, Cooper Z, Fairburn CG 1987 The develop- ment and validation of the Body Shape Questionnaire. Int J Eat Disord 6:485-494 (Pubitemid 17111165)
20. Livesey G, Elia M 1988 Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels. Am J Clin Nutr 47:608-628
21. Johannsen DL, Calabro MA, Stewart J, Franke W, Rood JC, Welk GJ 2010 Accuracy of armband monitors for measuring daily energy expenditure in healthy adults. Med Sci Sports Exerc 42:2134-2140
22. Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, Nguyen T, Martin CK, Volaufova J, Most MM, Greenway FL, Smith SR, Deutsch WA, Williamson DA, Ravussin E 2006 Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295:1539-1548
23. Martin CK, Heilbronn LK, de Jonge L, DeLany JP, Volaufova J, Anton SD, Redman LM, Smith SR, Ravussin E 2007 Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity (Silver Spring) 15:2964-2973 (Pubitemid 351256658)
24. 2C receptor mutant mice. Diabetes 52:315-320
25. Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O'Rahilly S, Heisler LK 2008 Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149:1323-1328 (Pubitemid 351397929)